舒利迭气雾剂与辅舒酮气雾剂在毛细支气管炎的早期干预中的对比研究

Comparative study of Seretide evohaler and Flixotide aerosol in early intervention of capillary bronchitis

目的观察舒利迭气雾剂在毛细支气管炎的早期干预中的疗效。方法选取2010年1月~2012年1月期间在广西儿童医院诊断为毛细支气管炎的患儿52例,随机分为治疗组和对照组,住院期间两组均常规给予抗病毒、平喘、化痰等常规治疗,出院后对照组给予吸入辅舒酮气雾剂,治疗组给予吸入舒利迭气雾剂,各早期干预3个月,比较两组出院后1年内喘息的发作次数、严重程度及住院次数、肺功能指标。结果治疗组喘息的发作次数、严重程度及住院次数、肺功能指标均优于对照组,差异均有统计学意义（P〈0.05）。结论舒利迭气雾剂在毛细支气管炎的早期干预中优于辅舒酮气雾剂,值得临床推广。

Objective To observe the curative effect of early intervention on aerosol in the treatment of bronchiolitis. Methods 52 cases of bronchiolitis from the Guangxi children＇s hospital form January 2010 to January 2012. The patients were randomly divided into two groups , the treatment group and the control group, all groups were given antiviral, asthma, phlegm and other conventional treatment during hospitalization. Discharge from hospital, the control group were received inhalation flixotide aerosol, the treatment group were given Seretide aerosol agent, for the early 3 months. observation of the the breathing frequency, severity, hospitalization days and lung function in 1year. Results In the treatment group, breathing frequency, severity and duration of hospitalization, pulmonary function indices were significantly different from the control group （P0.05）. Conclusion Seretide evohaler were better than flixotide aerosol in the early intervention on aerosol in the treatment of bronchiolitis, were worth for the clinical promotion.